Article Details

Global HER2+ breast cancer ADC market to reach $3.3bn by 2030 - Pharmaceutical Technology

Retrieved on: 2021-09-08 09:20:08

Tags for this article:

Click the tags to see associated articles and topics

Global HER2+ breast cancer ADC market to reach $3.3bn by 2030 - Pharmaceutical Technology. View article details on hiswai:

Excerpt

Antibody-drug conjugates (ADCs) are becoming increasingly prominent in the ... payloads with the unique targeting abilities of monoclonal antibodies.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up